FA
LMAT icon

Fedenia Advisers’s LeMaitre Vascular LMAT Stock Holding History

Fedenia Advisers’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-473
Closed -$43.6K – 286
2024
Q4 		$43.6K Buy
+473
New +$45.5K 0.03% 261

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fedenia Advisers's LMAT Position: Q1 2025 in Review

Fedenia Advisers sold out of LeMaitre Vascular (LMAT) in Q1 2025, closing a stake of 473 shares — an estimated $43.6K sold.

Fedenia Advisers first reported a position in LMAT in Q4 2024 and held it in 1 quarter. The position peaked at $43.6K in Q4 2024. 288 funds tracked by Wall St. Rank hold LMAT as of Q1 2025.

  • Fedenia Advisers reported no remaining LeMaitre Vascular position as of Q1 2025 after selling out during the quarter.
  • Fedenia Advisers sold 473 LeMaitre Vascular shares in Q1 2025, an estimated $43.6K.
  • Fedenia Advisers first reported a position in LeMaitre Vascular in Q4 2024 and held it in 1 quarter.
  • Fedenia Advisers's LeMaitre Vascular position peaked at $43.6K in Q4 2024.
  • 288 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2025.

Based on Fedenia Advisers's 13F filing for Q1 2025, filed 28 Apr 2025.